Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kada

Showing results (481-490 of 586) with videos related to

Pageof 59
Sort By:
Pediatric Blood & Cancer|April 11, 2022
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemiaHaruko Shima, Akiko Kada, Akihiko Tanizawa, et al.
JMIR Public Health and Surveillance|January 26, 2026
Establishing One Health Surveillance Platform for Electronic Integrated Disease Surveillance and Response in Malawi: Action Design Research StudyTsung-Shu Joseph Wu, Matthew Vundu Mvula, Edward Kada Koma Chado, et al.
Molecular Carcinogenesis|April 27, 2011
XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countriesNadia Laantri, Majida Jalbout, Meriem Khyatti, et al.
Plos One|April 10, 2020
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and olderKeisuke Ido, Ryota Kurogi, Ai Kurogi, et al.
BMJ Open|August 19, 2021
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care unitsGuillaume Voiriot, Muriel Fartoukh, Isabelle Durand-Zaleski, et al.
Acta Medica Okayama|August 25, 2018
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II StudyYuhki Koga, Shingo Baba, Reiji Fukano, et al.
Blood Purification|November 4, 2021
Renal Replacement Therapy for Acute Kidney Injury in French Intensive Care Units: A Nationwide Survey of PracticesJean-Pierre Quenot, Idris Amrouche, Jean-Yves Lefrant, et al.
Infectious Diseases and Therapy|August 9, 2021
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory FailureYuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, et al.
Acta Medica Okayama|April 21, 2018
High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm TrialKen Takase, Akiko Kada, Hiromi Iwasaki, et al.
Ejhaem|July 18, 2022
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patientsSatoshi Yamasaki, Akiko Kada, Ilseung Choi, et al.
Pageof 59

Showing results (481-490 of 586) with videos related to

Sort By:
Pageof 59
Pediatric Blood & Cancer|April 11, 2022
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemiaHaruko Shima, Akiko Kada, Akihiko Tanizawa, et al.
JMIR Public Health and Surveillance|January 26, 2026
Establishing One Health Surveillance Platform for Electronic Integrated Disease Surveillance and Response in Malawi: Action Design Research StudyTsung-Shu Joseph Wu, Matthew Vundu Mvula, Edward Kada Koma Chado, et al.
Molecular Carcinogenesis|April 27, 2011
XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countriesNadia Laantri, Majida Jalbout, Meriem Khyatti, et al.
Plos One|April 10, 2020
Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and olderKeisuke Ido, Ryota Kurogi, Ai Kurogi, et al.
BMJ Open|August 19, 2021
Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care unitsGuillaume Voiriot, Muriel Fartoukh, Isabelle Durand-Zaleski, et al.
Acta Medica Okayama|August 25, 2018
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II StudyYuhki Koga, Shingo Baba, Reiji Fukano, et al.
Blood Purification|November 4, 2021
Renal Replacement Therapy for Acute Kidney Injury in French Intensive Care Units: A Nationwide Survey of PracticesJean-Pierre Quenot, Idris Amrouche, Jean-Yves Lefrant, et al.
Infectious Diseases and Therapy|August 9, 2021
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory FailureYuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, et al.
Acta Medica Okayama|April 21, 2018
High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm TrialKen Takase, Akiko Kada, Hiromi Iwasaki, et al.
Ejhaem|July 18, 2022
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patientsSatoshi Yamasaki, Akiko Kada, Ilseung Choi, et al.
Pageof 59